Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals
Giuseppe Della Pepa, Claudia Vetrani, Gianluca Lombardi, et al.
Nutrients (2017) Vol. 9, Iss. 10, pp. 1065-1065
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
Johanna C. Arroyave-Ospina, Zongmei Wu, Yana Geng, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 174-174
Open Access | Times Cited: 344
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases
Maria Mirabelli, Eusebio Chiefari, Biagio Arcidiacono, et al.
Nutrients (2020) Vol. 12, Iss. 4, pp. 1066-1066
Open Access | Times Cited: 202
The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil
P. Ditano-Vázquez, José D. Torres‐Peña, Francisco Galeano‐Valle, et al.
Nutrients (2019) Vol. 11, Iss. 11, pp. 2833-2833
Open Access | Times Cited: 188
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
Michelle L. Boland, Denise Oró, K.S. Tølbøl, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 33, pp. 4904-4920
Open Access | Times Cited: 103
A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD
Mary P. Moore, Rory P. Cunningham, Ryan J. Dashek, et al.
Obesity (2020) Vol. 28, Iss. 10, pp. 1843-1852
Open Access | Times Cited: 97
Virgin avocado oil: An emerging source of functional fruit oil
Chin Xuan Tan
Journal of Functional Foods (2019) Vol. 54, pp. 381-392
Closed Access | Times Cited: 90
Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
Giuseppe Della Pepa, Marco Russo, Marilena Vitale, et al.
Diabetes Research and Clinical Practice (2021) Vol. 178, pp. 108984-108984
Closed Access | Times Cited: 64
Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease
Yue-Ming Gao, Weijia Chen, Zhenling Deng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 22
Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk
Lutgarda Bozzetto, Giuseppina Costabile, Giuseppe Della Pepa, et al.
Nutrients (2018) Vol. 10, Iss. 7, pp. 943-943
Open Access | Times Cited: 77
The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial
Bertha Araceli Marín-Alejandre, Itziar Abete, Irene Cantero, et al.
Nutrients (2019) Vol. 11, Iss. 10, pp. 2543-2543
Open Access | Times Cited: 68
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
Theresa Hydes, Sujan Ravi, Rohit Loomba, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 383-400
Open Access | Times Cited: 63
A Low ω-6 to ω-3 PUFA Ratio (n–6:n–3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth
Michelle Van Name, Mary Savoye, JENNIFER M. CHICK, et al.
Journal of Nutrition (2020) Vol. 150, Iss. 9, pp. 2314-2321
Open Access | Times Cited: 58
The influence of probiotics on bile acids in diseases and aging
Bhagavathi Sundaram Sivamaruthi, Lim Ai Fern, Dk Siti Najwa Rashidah Pg Hj Ismail, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 128, pp. 110310-110310
Open Access | Times Cited: 52
Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study
Maryam Hashemian, Shahin Merat, Hossein Poustchi, et al.
The American Journal of Gastroenterology (2021) Vol. 116, Iss. 8, pp. 1667-1675
Open Access | Times Cited: 42
Refining insights into rheumatoid arthritis-associated liver dysfunction: Opportunities for methodological advancements and clinical implications
Z. X. Liu, Peng Guo, Guohong Xiang, et al.
European Journal of Internal Medicine (2025)
Closed Access
Application of Generative Artificial Intelligence in Dyslipidemia Care
Fernando Bril, Gabriela Berg, Magalí Barchuk, et al.
Journal of Lipid and Atherosclerosis (2025) Vol. 14, Iss. 1, pp. 5-5
Open Access
Dietary Interventions for the Prevention of Type 2 Diabetes in High-Risk Groups: Current State of Evidence and Future Research Needs
Nicola Guess
Nutrients (2018) Vol. 10, Iss. 9, pp. 1245-1245
Open Access | Times Cited: 52
miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3
Qian Zhang, Kun Yu, Yazhen Cao, et al.
Life Sciences (2021) Vol. 270, pp. 119071-119071
Closed Access | Times Cited: 35
Evening chronotype is associated with severe NAFLD in obesity
Claudia Vetrani, Luigi Barrea, Ludovica Verde, et al.
International Journal of Obesity (2022) Vol. 46, Iss. 9, pp. 1638-1643
Closed Access | Times Cited: 26
Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial
Giuseppina Costabile, Giuseppe Della Pepa, Dominic Salamone, et al.
Nutrients (2022) Vol. 14, Iss. 10, pp. 2178-2178
Open Access | Times Cited: 24
Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Fernando Bril, Gabriela Berg, Magalí Barchuk, et al.
Journal of Lipid and Atherosclerosis (2025) Vol. 14, Iss. 1, pp. 69-69
Open Access
Impact of Helicobacter pylori Eradication on Clinical and Laboratory Parameters in Non-alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Fouad Jaber, Saqr Alsakarneh, Azizullah Beran, et al.
Current Medical Science (2025)
Closed Access
Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by “Junk Food”: Evidence for Anti-Inflammatory Activity
Maddalena Parafati, Antonella Lascala, Daniele La Russa, et al.
Nutrients (2018) Vol. 10, Iss. 11, pp. 1604-1604
Open Access | Times Cited: 39
<p>A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis</p>
Surosree Ganguli, Peter Deleeuw, Sanjaya K. Satapathy
Hepatic Medicine Evidence and Research (2019) Vol. Volume 11, pp. 159-178
Open Access | Times Cited: 37
Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
Rosa Lombardi, Federica Iuculano, Giada Pallini, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8761-8761
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top